tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PCRX Stock Latest News

Pacira granted RMAT designation for PCRX-201
The FlyPacira granted RMAT designation for PCRX-201
1M ago
PCRX
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
PremiumPress Releases
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
1M ago
PCRX
Pacira assumed with an Overweight at JPMorgan
PremiumThe Fly
Pacira assumed with an Overweight at JPMorgan
2M ago
PCRX
Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
PremiumPress Releases
Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
2M ago
PCRX
Pacira price target lowered to $40 from $50 at Barclays
PremiumThe Fly
Pacira price target lowered to $40 from $50 at Barclays
2M ago
PCRX
Pacira Pharmaceuticals CFO Transition and Financial Update
PremiumCompany AnnouncementsPacira Pharmaceuticals CFO Transition and Financial Update
2M ago
8K
PCRX
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
PremiumPress Releases
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
2M ago
PCRX
Pacira reports Q4 EPS 89c, consensus 88c
PremiumThe Fly
Pacira reports Q4 EPS 89c, consensus 88c
2M ago
PCRX
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
PCRX
Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy
PremiumPress Releases
Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy
2M ago
PCRX
Pacira announces publication of study of EXPAREL
PremiumThe Fly
Pacira announces publication of study of EXPAREL
2M ago
PCRX
Pacira awarded Brand Pharmaceuticals agreement with Premier
PremiumThe Fly
Pacira awarded Brand Pharmaceuticals agreement with Premier
3M ago
PCRX
Pacira named a top pick for 2024 at H.C. Wainwright
PremiumThe FlyPacira named a top pick for 2024 at H.C. Wainwright
3M ago
PCRX
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
PremiumPress Releases
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
4M ago
PCRX
Pacira reports preliminary FY23 revenue $675M, consensus $677.3M
PremiumThe Fly
Pacira reports preliminary FY23 revenue $675M, consensus $677.3M
4M ago
PCRX
Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress Releases
Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
4M ago
PCRX
Pacira Appoints Frank D. Lee as Chief Executive Officer
PremiumPress Releases
Pacira Appoints Frank D. Lee as Chief Executive Officer
4M ago
PCRX
Pacira appoints Frank Lee as CEO
PremiumThe Fly
Pacira appoints Frank Lee as CEO
4M ago
PCRX
Pacira initiated with an Outperform at Raymond James
PremiumThe Fly
Pacira initiated with an Outperform at Raymond James
4M ago
PCRX
Pacira consensus for 2024 looks too high, 2025 too low, says Jefferies
PremiumThe FlyPacira consensus for 2024 looks too high, 2025 too low, says Jefferies
5M ago
PCRX
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
PremiumPress Releases
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
6M ago
PCRX
Pacira announces FDA approval of expanded EXPAREL label
PremiumThe Fly
Pacira announces FDA approval of expanded EXPAREL label
6M ago
PCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >